Role of genetic factors (CETP gene Taq I B polymorphism and Apo A-I gene Msp I polymorphism) in serum HDL-C levels in women

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 14, Issue 1, 2004, Pages 6-14

  Motohashi, Y ^a,b   Maruyama, T ^c   Murata, M ^a   Nakano, S ^a   Maruyama, C ^d   Kyotani, S ^e   Tsushima, M ^a   Saruta, T ^a  

^a KEIO UNIVERSITY   (Japan)

^b Tokyo Metropolitan Ohtsuka Hospital   (Japan)

^c Saitama Social Insurance Hospital   (Japan)

^d JAPAN WOMEN'S UNIVERSITY   (Japan)

^e NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Apolipoprotein A I; Body mass index; Cholesteryl ester transfer protein (CETP); Gene; High density lipoprotein cholesterol (HDL C)

Indexed keywords

APOLIPOPROTEIN A1; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID;

ADULT; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENVIRONMENTAL FACTOR; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HEREDITY; HIGH RISK POPULATION; HUMAN; JAPAN; LIPID BLOOD LEVEL; MALE; MULTIPLE REGRESSION; NORMAL HUMAN; PREDICTION; RISK ASSESSMENT; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE;

EID: 2342652306     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0939-4753(04)80041-3     Document Type: Article

References (36)

1. Stampfer MJ, Sacks FM, Salvini S, Willett WC, Hennekens CH (1991) A protective study of cholesterol, apolipoproteins and the risk of myocardial infarction. N Engl J Med 325: 373-381
2. Tribble DL, Krauss RM (1993) HDL and coronary artery disease. Adv Intern Med 38: 1-29
3. Wilson PWF, Garrison RJ, Abbott RD, Castelli WP (1983) Factors associated with lipoprotein cholesterol levels: the Framingham study. Arteriosclerosis 3: 273-281
4. Craig WY, Palomaki GE, Haddow JE (1989) Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ 298: 784-788
5. Kiechl S, Willeit J, Rungger G, Egger G, Oberhollenzer F, Bonora E (1998) Alcohol consumption and atherosclerosis: what is the relation? Prospective results from the Bruneck study. Stroke 29: 900-907
6. Lloyd T, Chinchilli VM, Rollings N, Kieselhorts K, Tregea DF, Henderson NA, Sinoway LI (1998) Fruit consumption, fitness, and cardiovascular health in female adolescents: the Penn State Young Women's Health Study. Am J Clin Nutr 67: 624-630
7. Pulkkinen A, Lehto S, Viitanen L, Laakso M, Kareinen A (2000) Msp I polymorphism at +83 bp in intron 1 of human apolipoprotein A1 gene is associated with elevated levels of HDL cholesterol and apolipoprotein A1 in nondiabetic subjects but not in type 2 diabetic patients with coronary heart disease. Diabetes Care 23: 791-795
8. Kamboh MI, Aston CE, Nestlerode CM, McAllister AE, Hamman RF (1996) Haplotype analysis of two APOA1/Msp I polymorphisms in relation to plasma levels of apo A-I and HDL-cholesterol. Atherosclerosis 127: 255-262
9. Bhatnagar D, Durrington PN, Channon KM, Prais H, Mackness MI (1993) Increased transfer of cholesteryl esters from high density lipoproteins to low density and very low density lipoproteins in patients with angiographic evidence of coronary artery disease. Atherosclerosis 98: 25-32
10. Foger B, Luef G, Ritsch A, Schmidauer C, Doblinger A, Lechleitner M, Aichner F, Patsch JR (1995) Relationship of high-density lipoprotein subfractions and cholesteryl ester transfer protein in plasma to carotid artery wall thickness. J Mol Med 73: 369-372
11. Hester CB, Tall AR, Swenson TL, Weech PK, Marcel YL, Milne RW (1988) Monoclonal antibodies to the Mr 74000 cholesteryl ester transfer protein neutralize all of the cholesteryl ester and triglyceride transfer activities in human plasma. J Biol Chem 263: 5020-5023
12. Yen FT, Deckelbaum RJ, Mann CJ, Marcel YL, Milne RW, Tall AR (1989) Inhibition of cholesteryl ester transfer protein activity by monoclonal antibody: effects on cholesteryl ester formation and neutral lipid mass transfer in human plasma. J Clin Invest 83: 2018-2024
13. Hannuksela ML, Liinamaa MJ, Kesaniemi YA, Savolainen MJ (1994) Relation of polymorphisms in the cholesteryl ester transfer protein gene to transfer protein activity and plasma lipoprotein levels in alcohol drinkers. Atherosclerosis 110: 35-44
14. Kuivenhoven JA, de KP, Boer JM, Smalheer HA, Botma GJ, Seidell JC, Kastelein JJ, Pritchard PH (1997) Heterogeneity at the CETP gene locus. Influence on plasma CETP concentration and HDL cholesterol levels. Arterioscler Thromb Vasc Biol 17: 560-568
15. Hibibno T, Sakuma N, Sato T (1996) Higher level of plasma cholesteryl ester transfer protein activity from high-density lipoprotein to ApoB-containing lipoproteins in subjects with angiographically detectable coronary artery disease. Clin Cardiol 19: 483-486
16. Kondo I, Berg K, Drayne DT, Lawn RM (1989) DNA polymorphism at the locus for human cholesteryl ester transfer protein (CETP) is associated with high density lipoprotein cholesterol and lipoprotein levels. Clin Genet 35: 49-56
17. Kinoshita M, Teramoto T, Shimizu N, Kaneko K, Ohta M, Koike T, Hosogaya S, Ozaki Y, Kume S, Yamanaka M (1996) CETP is a determinant of serum LDL-cholesterol but not HDL-cholesterol in healthy Japanese. Atherosclerosis 120: 75-82
18. Marotti KR, Castle CK, Boyle TP, Lin AH, Murray RW, Melchior GW (1993) Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein. Nature 364: 73-75
19. Plump AS, Masucci-Magoulas L, Bruce C, Bisgaier CL, Breslow JL, Tall AR (1999) Increased atherosclerosis in apoE and LDL receptor gene knock-out mice as a result of human cholesteryl ester transfer protein transgene expression. Arterioscler Thromb Vasc Biol 19: 1105-1110
20. Sugano M, Makino N, Sawada S, Otsuka S, Watanabe M, Okamoto H, Kamada M, Mizushima A (1998) Effect of antisense oligonucleotides against cholesteryl ester transfer protein on the development of atherosclerosis in cholesterol-fed rabbits. J Biol Chem 273: 5033-5036
21. Hayek T, Masucci-Magoulas L, Jiang X, Walsh A, Rubin E, Breslow JL, Tall AR (1995) Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene. J Clin Invest 96: 2071-2074
22. Foger B, Chase M, Amar MJ, Vaisman BL, Shamburek RD, Paigen B, Fruchart-Najib J, Paiz JA, Koch CA, Hoyt RF, Brewer HB, Santamarina-Fojo S (1999) Cholesteryl ester transfer protein corrects dysfunctional high density lipoproteins and reduces aortic atherosclerosis in lecithin: cholesterol acyltransferase transgenic mice. J Biol Chem 274: 36912-36920
23. Stevenson CG (1998) Cholesterol ester transfer protein: a molecule with three faces? Crit Rev Clin Lab Sci 35: 517-546
24. Kuivenhoven JA, Jukema W, Zwinderman AH, Knijff P, McPherson R, Bruschke AVG, Lie KL, Kastelein JP (1998) The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. The Regression Growth Evaluation Statin Study Group. N Engl J Med 338: 86-93
25. Fumeron F, Betoulle D, Luc G, Behague I, Ricard S, Poirier O, Jemaa R, Evans A, Arveiler D, Marques-Vidal P, Bard JM, Fruchart JC, Ducimetiere P, Apfelbaum M, Cambien F (1995) Alcohol intake modulates the effect of a polymorphism of cholsteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction. J Clin Invest 96: 1664-1671
26. Paul-Hayase H, Rosseneu M, Robinson D, Van Bervliet JP, Deslypere JP, Humpheries SE (1992) Polymorphisms in the apolipoprotein (apo) AI-CIII-AIV gene cluster: detection of genetic variation determining plasma apo AI, apo CIII, apo AIV concentrations. Hum Genet 88: 439-446
27. Wang XL, Badenhop R, Humphrey KE, Wilcken DE (1995) C to T and/or G to A transitions are responsible for loss of a Msp I restriction site at the 5′-end of the human apolipoprotein AI gene. Hum Genet 95: 473-474
28. Yano Y, Irie N, Homma Y, Tsushima M, Takeuchi I, Nakaya N, Goto Y (1980) High density lipoprotein cholesterol levels in the Japanese. Atherosclerosis 36: 173-181
29. Freeman DJ, Griffin BA, Holmes AP, Lindsay GM, Gaffney D, Packard CJ, Shepherd J (1994) Regulation of plasma HDL cholesterol and subfraction distribution by genetic and environment factors. Associations between the Taq1B RFLP in the CETP gene and smoking and obesity. Arterioscler Thromb 14: 336-344
30. Wang XL, Badenhop R, Humphrey KE, Wilcken DE (1996) New Msp I polymorphism at +83 bp of the human apolipoprotein AI gene: association with increased circulating high density lipoprotein cholesterol levels. Genet Epidemiol 13: 1-10
31. Shemer R, Walsh A, Eisenberg S, Breslow JL, Razin A (1990) Tissue-specific methylation patterns and expression of human apolipoprotein AI gene. J Biol Chem 265: 1010-1015
32. Kamboh MI, Aston CE, Nestlerode CM, McAllister AE, Hamman RF (1996) Haplotype analysis of two APOA1/Msp I polymorphisms in relation to plasma levels of apo A-1 and HDL-cholesterol. Atherosclerosis 127: 255-262
33. Hsu LA, Ko YL, Hsu KH, Ko YH, Lee YS (2002) Genetic variations in the cholesteryl ester transfer protein gene and high density lipoprotein cholesterol levels in Taiwanese Chinese. Hum Genet 110: 57-63
34. Sigurdsson G Jr., Gudnason V, Sigurdsson G, Humphries SE (1992) Interaction between a polymorphism of the apo A-1 promoter region and smoking determines plasma levels of HDL and apo A-1. Arterioscler Thromb 12: 1017-1022
35. Talmud PJ, Ye S, Humphries SE on behalf of the EARS Group (1994) Polymorphism in the promoter region of the apolipoprotein A1 gene associated with differences in apolipoprotein A1 levels: The European Atherosclerosis Research Study. Genet Epidemiol 11: 265-280
36. Lusis AJ, Zollman S, Soarkes RS, Klisak I, Mohandas T, Drayna D, Lawn RM (1987) Assignment of the human gene for cholesteryl ester transfer protein to chromosome 16q12-16q21. Genomics 1: 232-235